-
1 day ago | 
endocrinologyadvisor.com | Steve Duffy
The table below is a review of notable updates that occurred in May 2025 for investigational products in development (not an inclusive list). Click on the status to view our full coverage. DrugPharmacologic ClassProposed IndicationStatusCardiovascular DiseaseAficamten (Cytokinetics)Cardiac myosin inhibitorTreatment of obstructive hypertrophic cardiomyopathy.
-
1 day ago | 
endocrinologyadvisor.com | Steve Duffy
DrugPharmacologic ClassIndicationMore InformationCardiovascular DiseaseHemiClor (low dose chlorthalidone)Thiazide-like diureticTreatment of hypertension in adults. HemiClor Approved for the Treatment of HypertensionDermatological DisordersZoryve (roflumilast) topical foam, 0.3%Phosphodiesterase type 4 inhibitorTreatment of plaque psoriasis of the scalp and body in adult and pediatric patients aged 12 years and older.
-
3 days ago | 
empr.com | Steve Duffy
The table below is a review of notable updates that occurred in May 2025 for investigational products in development (not an inclusive list). Click on the status to view our full coverage. DrugPharmacologic ClassProposed IndicationStatusCardiovascular DiseaseAficamten (Cytokinetics)Cardiac myosin inhibitorTreatment of obstructive hypertrophic cardiomyopathy.
-
1 week ago | 
empr.com | Steve Duffy
Please login or register first to view this content. Login Register
-
2 weeks ago | 
rheumatologyadvisor.com | Steve Duffy
US News & World Report has released its new over-the-counter (OTC) medicine and health product rankings for 2025-2026. The third annual Best OTC Medicine & Health Products list includes 12 new OTC product categories, bringing the total number of categories to 133. The results were reached via a survey, conducted in partnership with The Harris Poll, and included responses from 357 pharmacists and 134 dermatologists practicing in the US.
-
2 weeks ago | 
empr.com | Steve Duffy
Case Study: Explanation: A 41-year-old woman comes to the office with a progressive history of hair loss over the past year. She has noticed hair loss most predominantly on the top of her head, as well as her temple regions. Her mother has the same type of hair loss pattern. She has not tried any treatments and denies itchiness or a burning sensation of the scalp.
-
2 weeks ago | 
dermatologyadvisor.com | Steve Duffy
US News & World Report has released its new over-the-counter (OTC) medicine and health product rankings for 2025-2026. The third annual Best OTC Medicine & Health Products list includes 12 new OTC product categories, bringing the total number of categories to 133. The results were reached via a survey, conducted in partnership with The Harris Poll, and included responses from 357 pharmacists and 134 dermatologists practicing in the US.
-
2 weeks ago | 
ophthalmologyadvisor.com | Steve Duffy
US News & World Report has released its new over-the-counter (OTC) medicine and health product rankings for 2025-2026. The third annual Best OTC Medicine & Health Products list includes 12 new OTC product categories, bringing the total number of categories to 133. The results were reached via a survey, conducted in partnership with The Harris Poll, and included responses from 357 pharmacists and 134 dermatologists practicing in the US.
-
3 weeks ago | 
pulmonologyadvisor.com | Steve Duffy
US News & World Report has released its new over-the-counter (OTC) medicine and health product rankings for 2025-2026. The third annual Best OTC Medicine & Health Products list includes 12 new OTC product categories, bringing the total number of categories to 133. The results were reached via a survey, conducted in partnership with The Harris Poll, and included responses from 357 pharmacists and 134 dermatologists practicing in the US.
-
3 weeks ago | 
empr.com | Steve Duffy
At-home cervical cancer screening device gains clearance; the FDA indicates the it wants to remove pediatric fluoride products from the market; chikungunya vaccine is on-pause for some individuals; a subcutaneous autoinjector is approved to treat migraines; and the FDA will review a gene therapy for Hunter syndrome.
